Fingerprint
Dive into the research topics of 'Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically